151 related articles for article (PubMed ID: 15260009)
21. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
[TBL] [Abstract][Full Text] [Related]
22. Ovarian steroid cell tumour inducing virilisation in a postmenopausal woman.
Pinto AM; Martins MB; Oliveira N; Oliveira M
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35444026
[TBL] [Abstract][Full Text] [Related]
23. [A case of postmenopausal hyperandrogenism caused by a lipid cell tumor].
Witek A; Skałba P; Chełmicki Z; Pajak J
Wiad Lek; 2002; 55(1-2):125-30. PubMed ID: 12043310
[TBL] [Abstract][Full Text] [Related]
24. New onset alopecia and hirsutism in a postmenopausal women.
Bühler-Christen A; Tischler V; Diener PA; Brändle M
Gynecol Endocrinol; 2009 May; 25(5):324-7. PubMed ID: 19903039
[TBL] [Abstract][Full Text] [Related]
25. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
26. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
27. [Severe postmenopausal hyperandrogenism due to an ovarian lipoid cell tumor: a case report].
Bernasconi D; Del Monte P; Marinaro E; Marugo A; Marugo M
Minerva Endocrinol; 2004 Mar; 29(1):25-9. PubMed ID: 15258555
[TBL] [Abstract][Full Text] [Related]
28. Alopecia and hirsutism in a postmenopausal woman as the presenting complaint of ovarian hilus (Leydig) cell tumor.
Berbegal L; Albares MP; De-Leon FJ; Negueruela G
Actas Dermosifiliogr; 2015 Oct; 106(8):676-8. PubMed ID: 25910403
[No Abstract] [Full Text] [Related]
29. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
[TBL] [Abstract][Full Text] [Related]
30. Virilizing adrenal ganglioneuroma in a woman with subclinical Cushing syndrome.
Diab DL; Faiman C; Siperstein AE; Zhou M; Zimmerman RS
Endocr Pract; 2008; 14(5):584-7. PubMed ID: 18753101
[TBL] [Abstract][Full Text] [Related]
31. MORE THAN MEETS THE EYE IN A PATIENT WITH PCOS: ANDROGEN-SECRETING GRANULOSA CELL OVARIAN TUMOR IN A VIRILIZED WOMAN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS).
Harris AA; Kabadi UM
AACE Clin Case Rep; 2020; 6(4):e170-e173. PubMed ID: 32734001
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
33. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
Yetkin DO; Demirsoy ET; Kadioglu P
Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
[TBL] [Abstract][Full Text] [Related]
34. Ovarian thecoma with androgenic manifestations in a postmenopausal woman.
Siekierska-Hellmann M; Sworczak K; Babińska A; Wojtylak S
Gynecol Endocrinol; 2006 Jul; 22(7):405-8. PubMed ID: 16864153
[TBL] [Abstract][Full Text] [Related]
35. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
36. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
37. Hyperandrogenism caused by a rare adrenocortical oncocytic neoplasm with uncertain malignant potential: a case report and review of the literature.
Bao Z; He W; Di W; Gao H
Endocr J; 2023 Mar; 70(3):275-280. PubMed ID: 36384706
[TBL] [Abstract][Full Text] [Related]
38. Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour.
Picón MJ; Lara JI; Sarasa JL; Recasens JD; Clouet R; Gonzalo MA; Rovira A
Eur J Endocrinol; 2000 Jun; 142(6):619. PubMed ID: 10822225
[TBL] [Abstract][Full Text] [Related]
39. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
40. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
